NFV NEWS

TMCNet:  APRICUS BIOSCIENCES, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits

[March 10, 2014]

APRICUS BIOSCIENCES, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits

(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On March 10, 2014, Wendell Wierenga, Ph.D. was appointed to serve as a Class III director of Apricus Biosciences, Inc. (the "Company"). In connection with his appointment as a director, Dr. Wierenga was awarded a stock option grant for 100,000 shares of the Company's common stock under the Company's 2012 Stock Long Term Incentive Plan.


Item 8.01 Other Events.

On March 10, 2014, the Company provided an update to its corporate presentation.

The presentation is currently available on the Company's website and filed herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description 99.1 Corporate Presentation, dated March 10, 2014 2--------------------------------------------------------------------------------

[ Back To NFVZone's Homepage ]